ClinVar Miner

Submissions for variant NM_006949.4(STXBP2):c.1027-17CACCCTG[3]

dbSNP: rs776600326
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV002133742 SCV002452460 benign Familial hemophagocytic lymphohistiocytosis 5 2024-01-12 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003155467 SCV003845040 benign not specified 2023-02-20 criteria provided, single submitter clinical testing Variant summary: STXBP2 c.1027-8_1027-2dupCCCTGCA alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing. Several computational tools predict an impact on normal splicing: One predict the variant abolishes a 3' acceptor site. Two predict the variant weakens a 3' acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.007450 in 25100 Finnish control chromosomes in the gnomAD database, including 2 homozygotes. This frequency is significantly higher than estimated for a pathogenic variant in STXBP2 causing Familial Hemophagocytic Lymphohistiocytosis (0.007450 vs 0.0022), suggesting the variant is benign. To our knowledge, no occurrence of c.1027-8_1027-2dupCCCTGCA in individuals affected with Familial Hemophagocytic Lymphohistiocytosis and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign.
PreventionGenetics, part of Exact Sciences RCV003958872 SCV004770923 likely benign STXBP2-related disorder 2020-02-28 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.